A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DA / diffuse astrocytoma

[Related PubMed/MEDLINE]
Total Number of Papers: 48
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DA  (>> Co-occurring Abbreviation)
Long Form:   diffuse astrocytoma
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 c-Met Expression Is a Useful Marker for Prognosis Prediction in IDH-Mutant Lower-Grade Gliomas and IDH-Wildtype Glioblastomas. AA
2019 Clinical Significance of Molecular Diagnosis of Pilocytic Astrocytoma: A Case Report. AA, PA
2019 Prognostic Importance of Age, Tumor Location, and Tumor Grade in Grade II Astrocytomas: An Integrated Analysis of the Cancer Genome Atlas and the Surveillance, Epidemiology, and End Results Database. AA, GTR, HR, mIDH, SEER
2019 Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas. LGG, OD
2018 Chemotherapy of Diffuse Astrocytoma (WHO grade II) in Adults. FRT, PCV, TMZ
2018 Cognitive features and surgical outcome of patients with long-term epilepsy-associated tumors (LEATs) within the temporal lobe. AED, DNET, GG, LEATs, PA, PXA
2018 Evaluation of DNA ploidy with intraoperative flow cytometry may predict long-term survival of patients with supratentorial low-grade gliomas: Analysis of 102 cases. EOR, iFC, LGG, OD, OS, PFS
2018 MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. miR, PA, PLGG
2018 p53 expression and subcellular survivin localization improve the diagnosis and prognosis of patients with diffuse astrocytic tumors. AA, CNS, GB
10  2017 CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression. GBM, RFS, TIL
11  2017 Genetic alterations related to BRAF-FGFR genes and dysregulated MAPK/ERK/mTOR signaling in adult pilocytic astrocytoma. APA
12  2017 Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors. EZH2, GBMs
13  2017 High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients. AA
14  2017 IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over. AA, GBM, IHC, WHO
15  2017 Prognostic value of survivin and DNA topoisomerase IIalpha in diffuse and anaplastic astrocytomas. AA, Ki67, TIIalpha
16  2016 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas. 5hmC, 5mC, TET
17  2016 Expression profiling of RE1-silencing transcription factor (REST), REST corepressor 1 (RCOR1), and Synapsin 1 (SYN1) genes in human gliomas. AO, GBM, RCOR1, RE1, REST, SYN1
18  2016 Immunohistochemical expression of chemokine receptor CXCR3 and its ligand CXCL10 in low-grade astrocytomas and glioblastoma multiforme: A tissue microarray-based comparison. CKs, GBM, PA, TMA
19  2016 Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma. AA, DIA, GBM, MnSOD, OS, PFS
20  2016 Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers. ---
21  2016 Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades. ---
22  2016 [MRI-characteristics of epileptogenic supratentorial brain tumors in children]. DNET, GG
23  2015 An Eighteen Serum Cytokine Signature for Discriminating Glioma from Normal Healthy Individuals. AA, GBM, KEGG, PAM
24  2015 Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma. IDH1, LGG, MGMT, OA, OG
25  2015 IDH1 mutation is prognostic for diffuse astrocytoma but not low-grade oligodendrogliomas in patients not treated with early radiotherapy. IDH1, OS, PFS
26  2013 CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas. AA, DFS, GBM, PA, PI, RG
27  2012 BRAF alterations are frequent in cerebellar low-grade astrocytomas with diffuse growth pattern. PA, WHO
28  2012 Cathepsin D and its prognostic value in neuroepithelial brain tumors. AA, Cath D, GB, MB
29  2012 Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma. GT, OG
30  2012 Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma. AA, GBM, LI
31  2012 Histopathological malignant progression of grade II and III gliomas correlated with IDH1/2 mutation status. AA, GBM
32  2012 IDH1 mutations in diffusely infiltrating astrocytomas: grade specificity, association with protein expression, and clinical relevance. AA, GBM, WHO
33  2012 IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy. KPS, OA, OL, OS, PFS
34  2012 Immunohistochemical expression of IDH1 in gliomas: a tissue microarray-based approach. EPEN, GBM, OLIG, PA, TMA
35  2011 Factors predicting progression of low-grade diffusely infiltrating astrocytoma. LI, MVD, PFS, WHO
36  2011 Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review. AA, AEPN, EPN, GBM, PSCGs, TMZ
37  2010 Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. AA, GBM, IGF
38  2010 Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India. AA, EGFR, GBM, LOH
39  2008 Low grade diffuse gliomas: shared cellular composition and morphometric differences. OA, OL
40  2008 Outcome analysis of childhood low-grade astrocytomas. LGA, OS, PA, PFS
41  2007 Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival. AA, AO, GBM, OS, PA, PTN
42  2006 Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas. AA, GBM
43  2006 Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion. AA, GBM, PA
44  2005 Apoptosis and proliferation: correlation with p53 in astrocytic tumours. AA, AI, GBM, PI
45  2005 Immunohistochemical appearance of HNE-protein conjugates in human astrocytomas. AA, GB, HNE
46  2005 Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. AA, ASCL1, GBM
47  2004 Differential expression of sst1, sst2A, and sst3 somatostatin receptor proteins in low-grade and high-grade astrocytomas. AA, GBM
48  2003 Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors. LI, LOH